Search results for: 'rapid molecular diagnostics and peptid synthesis platforms'
- Did you mean
- radio molecular diagnostics and peptid synthetic platforms
- rapid molecular diagnostics ad peptid synthesis platforms
- Related search terms
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- diagnostics market outlook series
- peptid market gdp 1
- peptid market gap 1
- peptides market gp 1
-
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Jul 2023  |  North America  |  Market Research
Global Oncology Diagnostics in IVD Growth Opportunities
By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities
The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Feb 2016  |  North America  |  Market Research
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...
$1,500.00
Special Price $1,125.00 save 25 %
-
15 Nov 2023  |  North America  |  Market Research
Global Point-of-care Testing Growth Opportunities
Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural s...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Feb 2022  |  North America  |  Market Research
Global Molecular Imaging (MI) Equipment Growth Opportunities
Development of Novel Radiopharmaceuticals and Technical Advancements in AI and Hybrid Systems Fuel the Growth Pipeline
This research study presents an analysis of and growth opportunities for the global molecular imaging (MI) equipment market. It offers an in-depth analysis of the current trends, market size, revenue forecast (2022–2026), and market penetration of PET/CT, PET/MRI, SPECT, and SPECT/CT systems. Each year, more than 36 million MI procedures are per...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Sep 2004  |  North America  |  Market Research
U.S. Molecular Diagnostics Markets
The study provides a U.S. market scenario for molecular diagnostics markets. The markets are divided as Infectious diseases, cancer, and pharmacogenomics markets. Emerging markets in molecular diagnostics are also discussed. Product analysis and technology analysis are detailed in the study. The study provides competitive position of key market par...
$2,450.00
Special Price $1,837.50 save 25 %
-
30 Nov 2006  |  North America  |  Market Research
U.S. Molecular Diagnostics Markets
This research service provides market intelligence, analysis, and forecasts for the U.S. molecular diagnostics markets. The products discussed in this research service are in vitro diagnostic kits, consumables, and instruments. A detailed analysis is provided with regard to these products and the companies that manufacture and distribute them. The...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Jul 2022  |  North America  |  Market Research
United States Molecular Point-of-Care Testing Growth Opportunities
Syndromic Point-of-Care Testing Drives Transformational Growth in Infectious Disease Diagnostics
Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or hours. Nu...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %